The company said Tuesday it would take a $980 million write-down stemming from the deal on top of earlier impairment charges.

The potential sale comes as the Golden Valley-based food company restructures, including cost-cutting, potential layoffs and ...

Starbucks CEO Brian Niccol told Reuters on Tuesday that he would accelerate the rollout of the coffeehouse chain's new ...

Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed ...